FMR1 and fragile X syndrome: We recently demonstrated that mTOR, a protein kinase in the phosphatidylinositol 3-kinase (PI3K) pathway, is a direct target of FMRP and that tissue from male FXS patients and Fmr1 KO mice expressed higher levels of mTOR10.